Synonyms LEAP-2, LEAP2, liver enriched antimicrobial peptide 2 + [1] |
Introduction Has an antimicrobial activity. |
Target |
Mechanism GHSR antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism LEAP2 modulators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date24 Aug 2022 |
Sponsor / Collaborator- |
Start Date24 May 2021 |
Sponsor / Collaborator |
Start Date17 Nov 2020 |
Sponsor / Collaborator |